North America eClinical solutions Market Size, Share & Industry Trends Analysis Report By Delivery Mode, By Product, By Clinical Trials Phase (Phase III, Phase II, Phase IV and Phase I), By End User, By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the North America eClinical solutions Market
Market Report Description
The North America eClinical solutions Market would witness market growth of 12.9% CAGR during the forecast period (2022-2028).
Clinical trial data is known to be gathered and managed by electronic data capture systems on a digital platform, in place of the traditional paper-based data capture methods. The deployment of such systems not only enables researchers to record data securely but also speeds up the study process and ensures data reuse.
The majority of EDC systems in use today are cloud-based, enabling secured remote access, which is a crucial aspect to notice in this context. Some of the potential advantages of utilizing EDC systems include secured access, simple installation and setup, high-quality data acquisition, decreased research time and expense, and simple compliance.
Growing demands for patient compliance are driving up demand for eCOA solutions that can successfully address issues with paper-based data. The main benefits of eCOA include the removal of data variance hazards, streamlined information, and reduced site monitoring costs. Additionally, the necessity of integrating clinical research studies with patient care, which results in a more patient-centric approach, is anticipated to support the market expansion.
The United States government’s healthcare initiatives aim to contribute to broader U.S. development objectives, foreign policy priorities, and national security concerns while also assisting in the improvement of the health of people in low- and middle-income nations. Since it began participating in international health initiatives more than a century ago, the United States is now the world's top financier and implementer of health initiatives. These initiatives include a wide range of United States government departments and agencies, congressional committees, and financial sources.
The US market dominated the North America eClinical Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $5,804.5 Million by 2028. The Canada market would showcase a CAGR of 15.5% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 14.5% during (2022 - 2028).
Based on Delivery Mode, the market is segmented into Web-based (on-demand) Model, Licensed enterprise (On-premise) Model and Cloud-based (SaaS) Model. Based on Product, the market is segmented into CDMS/EDC Solutions, CTMS Solutions, Analytics & Reporting Platforms, Safety Solutions, Integration Platforms, RTMS Solutions, eCOA Solutions and Others. Based on Clinical Trials Phase, the market is segmented into Phase III, Phase II, Phase IV and Phase I. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutions, Hospitals, Contract Research Organizations, Medical Device Manufacturers and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, Anju Software, Inc., eClinical Solutions LLC, Castor EDC, Signant Health, Dassault Systemes SE, Parexel International Corporation (Phoenix Parentco, Inc.), Clario, BSI Life Sciences (Business Systems Integration AG) and MedNet Solutions
Scope of the Study
Market Segments Covered in the Report:
By Delivery Mode
- Web-based (on-demand) Model
- Licensed enterprise (on-premise) Model
- Cloud-based (saas) Model
- CDMS/EDC Solutions
- CTMS Solutions
- Analytics & Reporting Platforms
- Safety Solutions
- Integration Platforms
- RTMS Solutions
- eCOA Solutions
By Clinical Trials Phase
- Phase III
- Phase II
- Phase IV
- Phase I
By End User
- Pharmaceutical & Biopharmaceutical Companies
- Academic Research Institutions
- Contract Research Organizations
- Medical Device Manufacturers
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Oracle Corporation
- Anju Software, Inc.
- eClinical Solutions LLC
- Castor EDC
- Signant Health
- Dassault Systemes SE
- Parexel International Corporation (Phoenix Parentco, Inc.)
- BSI Life Sciences (Business Systems Integration AG)
- MedNet Solutions
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free